Showing results (1-10 of 234) with videos related to
Sort By:
Pageof 24
Annual Review of Pharmacology and Toxicology|January 9, 2013
Design of peptide and peptidomimetic ligands with novel pharmacological activity profilesVictor J Hruby, Minying CaiCurrent Protein & Peptide Science|February 27, 2016
The Melanocortin Receptor System: A Target for Multiple Degenerative DiseasesMinying Cai, Victor J HrubyCurrent Topics in Medicinal Chemistry|August 20, 2009
Melanotropins as drugs for the treatment of obesity and other feeding disorders: potential and problemsMinying Cai, Joel Nyberg, Victor J HrubyExpert Opinion on Drug Discovery|June 1, 2012
Approaches to the rational design of selective melanocortin receptor antagonistsVictor J Hruby, Minying Cai, Joel Nyberg, et al.Molecules (Basel, Switzerland)|October 2, 2019
Development of N-Acetylated Dipalmitoyl-S-Glyceryl Cysteine Analogs as Efficient TLR2/TLR6 AgonistsYang Zhou, Abid H Banday, Victor J Hruby, et al.European Journal of Pharmacology|January 7, 2011
Design of novel melanocortin receptor ligands: multiple receptors, complex pharmacology, the challengeVictor J Hruby, Minying Cai, James Cain, et al.Journal of Medicinal Chemistry|August 9, 2003
Structure-activity relationships of novel cyclic alpha-MSH/beta-MSH hybrid analogues that lead to potent and selective ligands for the human MC3R and human MC5RPreeti Balse-Srinivasan, Paolo Grieco, Minying Cai, et al.Peptides|November 24, 2005
Structure-activity studies of new melanocortin peptides containing an aromatic amino acid at the N-terminal positionPaolo Grieco, Minying Cai, Alexander V Mayorov, et al.Journal of Medicinal Chemistry|October 31, 2003
Structure-activity relationships of gamma-MSH analogues at the human melanocortin MC3, MC4, and MC5 receptors. Discovery of highly selective hMC3R, hMC4R, and hMC5R analoguesPreeti Balse-Srinivasan, Paolo Grieco, Minying Cai, et al.Pageof 24